This study revealed that EBAG9 modulates the expression of EMT-related genes containing VIM, SNAI1, and SNAI2 in prostate cancer cells, suggesting that EBAG9 could stimulate cancer progression and invasion through EMT pathway. Here, EBAG9 is linked to prostate carcinoma.